HK1085373A1 - Compound and use in the manufacture of a medicament for the treatment of benign prostatic hyperplasia and associated symptoms - Google Patents
Compound and use in the manufacture of a medicament for the treatment of benign prostatic hyperplasia and associated symptomsInfo
- Publication number
- HK1085373A1 HK1085373A1 HK05108113.0A HK05108113A HK1085373A1 HK 1085373 A1 HK1085373 A1 HK 1085373A1 HK 05108113 A HK05108113 A HK 05108113A HK 1085373 A1 HK1085373 A1 HK 1085373A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- medicament
- manufacture
- compound
- treatment
- benign prostatic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0322395A GB0322395D0 (en) | 2003-09-24 | 2003-09-24 | Methods for treating bladder dysfunction and related compounds and compositions |
GB0325598A GB2407499B (en) | 2003-11-03 | 2003-11-03 | Vitamin D3 analogue for use in the treatment of BPH |
GB0416876A GB0416876D0 (en) | 2004-07-29 | 2004-07-29 | Compound and use in treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1085373A1 true HK1085373A1 (en) | 2006-08-25 |
Family
ID=34229055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05108113.0A HK1085373A1 (en) | 2003-09-24 | 2005-09-16 | Compound and use in the manufacture of a medicament for the treatment of benign prostatic hyperplasia and associated symptoms |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1673096A1 (fr) |
JP (2) | JP2007506699A (fr) |
CN (1) | CN100488511C (fr) |
BE (1) | BE1016292A3 (fr) |
BR (1) | BRPI0404050A (fr) |
CH (1) | CH698144B1 (fr) |
EA (1) | EA010240B1 (fr) |
FR (1) | FR2859910B1 (fr) |
HK (1) | HK1085373A1 (fr) |
NL (1) | NL1027109C2 (fr) |
NZ (1) | NZ535531A (fr) |
WO (1) | WO2005027923A1 (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100965205B1 (ko) * | 2004-10-05 | 2010-06-24 | 깃세이 야쿠힌 고교 가부시키가이샤 | 하부요로 폐색 질환에 따른 축뇨장해의 예방 및/또는치료제 |
PL1806136T3 (pl) * | 2004-10-06 | 2012-04-30 | Kissei Pharmaceutical | Kompozycja medyczna do zapobiegania przejściu na leczenie operacyjne łagodnego rozrostu gruczołu krokowego |
US20100009949A1 (en) * | 2006-03-24 | 2010-01-14 | Bioxell S.P.A. | Novel method |
US8221803B1 (en) | 2007-06-25 | 2012-07-17 | OncoNatural Solutions, Inc. | Composition for prostate health |
US20120164240A1 (en) | 2010-12-22 | 2012-06-28 | Audino David Lawrence | Enriched a. blitoides compositions and uses thereof |
US20170049834A1 (en) * | 2015-08-18 | 2017-02-23 | Golden Biotechnology Corporation | Benign prostatic hyperplasia add-on therapy |
FR3063906A1 (fr) * | 2017-03-20 | 2018-09-21 | Pierre Fabre Medicament | Utilisation de l'oleoresine de copaifera dans les pathologies de la prostate |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5763429A (en) * | 1993-09-10 | 1998-06-09 | Bone Care International, Inc. | Method of treating prostatic diseases using active vitamin D analogues |
TW403735B (en) * | 1995-11-22 | 2000-09-01 | Hoffmann La Roche | 25-hydroxy-16-ene-26, 27-bishomo-cholecalciferol |
SG70009A1 (en) * | 1996-05-23 | 2000-01-25 | Hoffmann La Roche | Vitamin d3 analogs |
US5872113A (en) * | 1997-05-16 | 1999-02-16 | Syntex (U.S.A.) Inc. | Fluorinated vitamin D3 analogs |
DE69832699T2 (de) * | 1997-05-16 | 2006-08-24 | Woman & Infants Hospital | Zyklische äther vitamin d3 verbindungen, 1alfa(oh) 3-epi-vitamin d3 verbindungen und deren verwendungen |
US6255501B1 (en) * | 1999-04-26 | 2001-07-03 | Hoffman-La Roche Inc. | Process for preparing antiosteoporotic agents |
US8496960B2 (en) * | 2001-10-23 | 2013-07-30 | Purdue Pharma L.P. | Terazosin transdermal device and methods |
CA2469119A1 (fr) * | 2001-12-03 | 2003-06-12 | Novacea, Inc. | Compositions pharmaceutiques comprenant des composes actifs de vitamine d |
-
2004
- 2004-09-22 BR BR0404050-3A patent/BRPI0404050A/pt not_active IP Right Cessation
- 2004-09-22 CH CH01553/04A patent/CH698144B1/fr not_active IP Right Cessation
- 2004-09-23 EA EA200401100A patent/EA010240B1/ru not_active IP Right Cessation
- 2004-09-23 NZ NZ535531A patent/NZ535531A/xx unknown
- 2004-09-23 FR FR0410073A patent/FR2859910B1/fr not_active Expired - Fee Related
- 2004-09-24 NL NL1027109A patent/NL1027109C2/nl not_active IP Right Cessation
- 2004-09-24 EP EP04765598A patent/EP1673096A1/fr not_active Withdrawn
- 2004-09-24 BE BE2004/0472A patent/BE1016292A3/nl not_active IP Right Cessation
- 2004-09-24 JP JP2006527365A patent/JP2007506699A/ja not_active Abandoned
- 2004-09-24 WO PCT/EP2004/010760 patent/WO2005027923A1/fr active Application Filing
- 2004-09-24 CN CNB2004100800817A patent/CN100488511C/zh not_active Expired - Fee Related
-
2005
- 2005-09-16 HK HK05108113.0A patent/HK1085373A1/xx not_active IP Right Cessation
-
2008
- 2008-08-18 JP JP2008209429A patent/JP2009035559A/ja not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2005027923A1 (fr) | 2005-03-31 |
EP1673096A1 (fr) | 2006-06-28 |
EA200401100A1 (ru) | 2005-04-28 |
BE1016292A3 (nl) | 2006-07-04 |
CH698144B1 (fr) | 2009-05-29 |
EA010240B1 (ru) | 2008-06-30 |
CN100488511C (zh) | 2009-05-20 |
JP2009035559A (ja) | 2009-02-19 |
JP2007506699A (ja) | 2007-03-22 |
FR2859910A1 (fr) | 2005-03-25 |
NZ535531A (en) | 2006-03-31 |
FR2859910B1 (fr) | 2006-04-28 |
NL1027109A1 (nl) | 2005-03-29 |
BRPI0404050A (pt) | 2005-06-14 |
NL1027109C2 (nl) | 2005-05-03 |
CN1615891A (zh) | 2005-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1226399A1 (zh) | 噠嗪衍生物及其作爲治療劑的用途 | |
IL169685A0 (en) | Treatment of benign prostatic hyperplasia using energolytic agents | |
IL178012A0 (en) | Diphenyl-indol-2-on compounds and their use in the treatment of cancer | |
HK1073997A1 (en) | Administration of agents for the treatment of inflammation | |
IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
PL370029A1 (en) | 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer | |
HK1086488A1 (en) | Compound and use thereof for the treatment of cancer | |
HK1089376A1 (en) | Formulation for use in the prevention and treatment of carbohydrate induced ; diseases and conditions | |
IL186604A0 (en) | Therapeutic combination in case of benign prostate hyperplasia | |
HK1080840A1 (en) | Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases | |
HK1085373A1 (en) | Compound and use in the manufacture of a medicament for the treatment of benign prostatic hyperplasia and associated symptoms | |
IL161744A (en) | Use of zd6474 and taxane in the manufacture of a medicament for the treatment of cancer and pharmaceutical compositions and kits comprising such compounds | |
AU2003212634A8 (en) | Compounds useful in the treatment of cancer | |
HK1105288A1 (en) | Flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer | |
ZA200210316B (en) | Composition and its therapeutic use. | |
EG24959A (en) | Indoles useful in the treatment of androgenreceptor related diseases. | |
IL162941A0 (en) | Carboxamidine derivatives and their use in the treatment of vascular diseases | |
IL160722A0 (en) | Aryloxypropylamines as chemosensitizing agents in the treatment of cancer | |
TWI365187B (en) | 7-azaindoles and the use thereof as therapeutic agents | |
IL166062A0 (en) | Compositions and methods for therapeutic treatment | |
GB0301016D0 (en) | Treatment of benign prostatic hyperplasia | |
EP1583543A4 (fr) | Procedes et compositions therapeutiques pour le traitement d'un cancer avance | |
EP1684795A4 (fr) | Procedes et agents pour le traitement du cancer | |
HUP0300876A3 (en) | Use of diclofenac for the manufacture of medicament for the topical treatment of burns | |
PL373000A1 (en) | Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20120924 |